Grant: Discovery Grants Program - Individual
University of Manitoba
$41,000.00
Novel functions of high mobility group A chromatin-binding factors
FY 2024-25
Summary
My lab focuses on identifying novel mechanistic functions of the architectural chromatin-binding protein High Mobility Group A2 (HMGA2) that integrate RNA- and DNA-binding to regulate dynamic protein interactomes and their spatiotemporal association with chromatin in cellular differentiation and genome protection. HMGA2 and structurally related HMGA1 epigenetic regulators modulate chromatin compaction using three basic AT hook domains. Differences between HMGA1 and HMGA2 proteins in their aa composition, linker domains, and C-terminus determine selective protein/DNA interactions that determine their distinct functions. High cellular levels of HMGA2 are present in stem cells and adult cells with high plasticity. My lab discovered that HMGA2 enhances the activity of the chromatin surveillance protein PARP1 for increased Poly-ADPribose (PAR) polymer assembly, which represents a new way of HMGA2 mediated modulation of protein-protein and chromatin-protein interactions. My BioID2 interactomes confirmed PARP1 as a critical partner during DNA damage and identified novel protein interactors that suggest novel functions of HMGA2 in mitosis.
I hypothesize that the HMGA2 functional interactome is critically influenced by PARylation. This alters the composition of HMGA2-PARP1 interactomes and protein-chromatin complexes.
My proposed discovery research will (1) explore the molecular basis for the HMGA2 functional interaction with PARP1, (2) investigate PAR-protein assemblies under DNA stress, and (3) explore new HMGA2 functional protein complexes in G2/mitosis.
Methodology: Employing defined structural HMGA2 mutants, including HMGA2K56E mutant for which I generated knock-in mice in my lab, I will use immunoprecipitation and PARP1 activity assays to identify the structural requirements for HMGA2-PARP1 binding and PARP1 mediated HMGA2 PARylation. I will use EMSA to test the ability of HMGA2 mutants to enhance PARP1 activity in the presence of branched DNA conformations representing distinct DNA lesions. Using male and female embryonic fibroblasts from HMGA2WT and HMGA2K56E mutant mice for split-Turbo BioID proximity proteomics, I will identify protein interactors that depend on functional HMGA2-PARP1 complexes. HMGA2 Mini-TurboID interaction proteomics in synchronized cells will monitor HMGA2 interactors with roles at centromeres and in mitosis identified in my lab. In-vivo PARylation labeling with biotin-tagged NAD+ during G2/M will identify cell cycle dependent PAR association of HMGA2 with novel HMGA2 interactor NuMA, a nuclear matrix protein with functions in mitosis.
Significance: Elucidating how HMGA2 recruits PAR for the dynamic assembly of HMGA2 interactomes will provide novel insight into mechanisms by which this intrinsically disordered nuclear protein can influence diverse nuclear functions.
Program
Discovery Grants Program - Individual
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05450
Name nom
Hombach-Klonisch, Sabine
Department département
Human Anatomy and Cell Science
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Novel functions of high mobility group A chromatin-binding factors
Keywords
high mobility group protein a2; protein interaction; parp1; hmga2 molecular domains; genome integrity; dna binding; adpribose polymer; centromere; proximity ligation; dna stress
Application summary
My lab focuses on identifying novel mechanistic functions of the architectural chromatin-binding protein High Mobility Group A2 (HMGA2) that integrate RNA- and DNA-binding to regulate dynamic protein interactomes and their spatiotemporal association with chromatin in cellular differentiation and genome protection. HMGA2 and structurally related HMGA1 epigenetic regulators modulate chromatin compaction using three basic AT hook domains. Differences between HMGA1 and HMGA2 proteins in their aa composition, linker domains, and C-terminus determine selective protein/DNA interactions that determine their distinct functions. High cellular levels of HMGA2 are present in stem cells and adult cells with high plasticity. My lab discovered that HMGA2 enhances the activity of the chromatin surveillance protein PARP1 for increased Poly-ADPribose (PAR) polymer assembly, which represents a new way of HMGA2 mediated modulation of protein-protein and chromatin-protein interactions. My BioID2 interactomes confirmed PARP1 as a critical partner during DNA damage and identified novel protein interactors that suggest novel functions of HMGA2 in mitosis.
I hypothesize that the HMGA2 functional interactome is critically influenced by PARylation. This alters the composition of HMGA2-PARP1 interactomes and protein-chromatin complexes.
My proposed discovery research will (1) explore the molecular basis for the HMGA2 functional interaction with PARP1, (2) investigate PAR-protein assemblies under DNA stress, and (3) explore new HMGA2 functional protein complexes in G2/mitosis.
Methodology: Employing defined structural HMGA2 mutants, including HMGA2K56E mutant for which I generated knock-in mice in my lab, I will use immunoprecipitation and PARP1 activity assays to identify the structural requirements for HMGA2-PARP1 binding and PARP1 mediated HMGA2 PARylation. I will use EMSA to test the ability of HMGA2 mutants to enhance PARP1 activity in the presence of branched DNA conformations representing distinct DNA lesions. Using male and female embryonic fibroblasts from HMGA2WT and HMGA2K56E mutant mice for split-Turbo BioID proximity proteomics, I will identify protein interactors that depend on functional HMGA2-PARP1 complexes. HMGA2 Mini-TurboID interaction proteomics in synchronized cells will monitor HMGA2 interactors with roles at centromeres and in mitosis identified in my lab. In-vivo PARylation labeling with biotin-tagged NAD+ during G2/M will identify cell cycle dependent PAR association of HMGA2 with novel HMGA2 interactor NuMA, a nuclear matrix protein with functions in mitosis.
Significance: Elucidating how HMGA2 recruits PAR for the dynamic assembly of HMGA2 interactomes will provide novel insight into mechanisms by which this intrinsically disordered nuclear protein can influence diverse nuclear functions.